title: The cytotoxic activity of lactoperoxidase: enhancement and inhibition by neuroactive compounds.
abstract: Neuronal death associated with Parkinson's disease is commonly believed to be caused by oxygen- and nitrogen-derived free radical species. Some years ago, however, we showed that peroxidase from the midbrain of dogs is able to kill various cell types, including neuroblastoma cells (M. B. Grisham et al., J. Neurochem. 48: 876-882: 1987). We postulated that a nigral peroxidase may play a significant role in the degeneration of dopaminergic neurons in Parkinson's disease. To further establish proof of principle, we recently performed a series of experiments using horseradish peroxidase and lactoperoxidase. We showed that the cytotoxic activity of lactoperoxidase is fully inhibited by physiological concentrations of dopamine, reduced glutathione, and L-cysteine, as well as by micromolar concentrations of apomorphine, desferal, aspirin, and uric acid. l-Methyl-4-phenyl-1,2-dihydropyridine (MPDP) and l-methyl-4-phenylpyridinium (MPP+) augment the cytotoxic activity, whereas l-methyl-4-phenyl-1,2,3,6-tetrahydropyridine, deprenyl, and pargyline had minimal or no effect. We also showed that horseradish peroxidase catalyzes the oxidation of MPDP to MPP+. Thus, contrary to the generally accepted theory that the in vivo oxidation of MPDP occurs spontaneously, this reaction may be catalyzed by a brain peroxidase. These observations lend further support to the suggestion that a brain peroxidase may play an important role in the metabolic events associated with Parkinson's disease.
authors.affiliation: Cell Biology and Biochemistry, Texas Tech University Health Sciences Center, Lubbock, TX 79430, USA. Johannes.Everse@ttuhsc.edu
authors.forename: Johannes
authors.initials: J
authors.lastname: Everse
authors.forename: Penelope W
authors.initials: PW
authors.lastname: Coates
mesh_terms: D015655:1-Methyl-4-phenylpyridinium / Q000494:pharmacology; D000818:Animals; D001058:Apomorphine / Q000494:pharmacology; D001241:Aspirin / Q000494:pharmacology; D001921:Brain / Q000201:enzymology / Q000378:metabolism*; D002384:Catalysis; D045744:Cell Line, Tumor; D004285:Dogs; D004298:Dopamine / Q000378:metabolism; D004912:Erythrocytes / Q000378:metabolism; D005609:Free Radicals; D006540:Herbicides / Q000494:pharmacology; D006801:Humans; D007784:Lactoperoxidase / Q000502:physiology*; D009474:Neurons / Q000378:metabolism / Q000473:pathology*; D010300:Parkinson Disease / Q000378:metabolism / Q000473:pathology; D009195:Peroxidase / Q000378:metabolism; D011726:Pyridinium Compounds / Q000494:pharmacology; D013053:Spectrophotometry; D013997:Time Factors; D014527:Uric Acid / Q000494:pharmacology
chemical_list: D005609:Free Radicals; D006540:Herbicides; D011726:Pyridinium Compounds; D014527:Uric Acid; C044755:1-methyl-4-phenyl-2,3-dihydropyridinium; D007784:Lactoperoxidase; D009195:Peroxidase; D001058:Apomorphine; D001241:Aspirin; D015655:1-Methyl-4-phenylpyridinium; D004298:Dopamine